CHI's 2nd Annual Implications of HUMAN GENETIC VARIATION: SNP's, Polymorphisms, Diseases & Treatments
	Cambridge Healthtech Institute (CHI) , Boston, Massachusetts October 21-22, 1999
	Individual human genomes exhibit differences, on average, at least once per 1000 bases, or a total of more than 3 million variances per person. This variation, typically in the form of single nucleotide polymorphisms (SNPs), is critical for identification of disease genes, particularly for multigenic disorders, and for understanding genetic differences in individual responses to the environment, to disease and to therapies. The task of understanding even a fraction of these correlations, deciphering which polymorphisms are significant and which are inconsequential, is awesome. Genotyping the number of individuals and loci that will need to be assessed, whether for investigative research or population screening purposes, is also daunting, and will require industrialization of any process employed. The potential value of such knowledge, however, is sufficient to provide the incentive for feverish research to enable better diagnostic, prognostic and therapeutic results to be achieved.
	Organized by:	CHI
	Deadline for Abstracts:	September 10,1999
	Registration:	For more details and to register on-line, please go to our website.
	Email for Requests and Registration:	jlaakso@healthtech.com
	Posted by: Jennifer Laakso   Host: wks137.healthtech.com date: June 11, 1999 13:53:03 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.